Table 1.

Prevalence of HGV/GBV-C Anti E2 and RNA among Iranian voluntary blood donors

Reference	City	Total number tested	Anti E2 N (%)	HGV RNA n (%)
Ramezani et al. [13]	Tabriz	478	5 (1)	0 (0)
Gharehbaghian et al. [14]	Tehran	330	14 (14.2)	–
Amini Kafi-Abad et al. [15]	Tehran	100	–	1 (1)
Rezvan et al. [16]	Tehran	514	44 (8.6)	–
Salehi et al. [17]	Isfahan	40	2 85)	–
Amini Kafl-Abad et al. [18]	Tehran	400	–	19 (4.8)
Total		1,862	65 (4.8)	20 (2)